Sagent Pharmaceuticals Announces the Introduction of

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
Sagent Pharmaceuticals Announces the Introduction of Oxaliplatin Injection, USP

SCHAUMBURG, Ill., Sept. 23, 2014 (GLOBE NEWSWIRE) -- Sagent Pharmaceuticals, Inc. (Nasdaq: SGNT ) today announced the introduction of Oxaliplatin Injection, USP, an antineoplastic agent, now in two liquid presentations. According to IMS, for the 12 months ending July 2014, the US market for Oxaliplatin approximated $102 million. As with all products in Sagent's portfolio, Oxaliplatin features Sagent's PreventIV Measures SM packaging and labeling, designed to help reduce the risk of medication errors.

"Jiangsu Hengrui Medicine Co. is a key strategic partnership for Sagent. We are pleased to launch Oxaliplatin Injection, USP, which is the second of many products we plan to launch under this partnership," said Jeffrey M. Yordon, Chief Executive Officer and Chairman of the Board.

About Oxaliplatin Injection, USP

Oxaliplatin Injection, USP, used in combination with infusional 5-fluorouracil/leucovorin, is indicated for adjuvant treatment of stage III colon cancer in patients who have undergone complete resection of the primary tumor and for treatment of advanced colorectal cancer.

The package insert, available at www.sagentpharma.com , contains the indications, boxed warning, complete side effect profile and prescribing information.

About Sagent Pharmaceuticals, Inc.

Sagent Pharmaceuticals, Inc. is a specialty pharmaceutical company focused on developing, manufacturing, sourcing and marketing pharmaceutical products, with a specific emphasis on injectables.  Sagent has created a unique global network of resources, comprising rapid development capabilities, sophisticated manufacturing and innovative drug delivery technologies, resulting in an extensive and rapidly expanding pharmaceutical product portfolio that fulfills the evolving needs of patients.

About Jiangsu Hengrui Medicine Co.

Jiangsu Hengrui Medicine Co., Ltd is an innovative pharmaceutical company and the leading provider of antineoplastic and surgical medications in China. It is also the first Chinese company with injectable products approved by US FDA and EU Authorities. Jiangsu Hengrui Medicine Co., Ltd is listed in the Shanghai Stock Exchange and the stock code is 600276.

INVESTOR CONTACT: Jonathon Singer, Sagent 847-908-1605

Scroll down for more posts ▼

Top 10 Most Recent News Articles

SOCaaS Market Grows to $16.68B by 2031, What It Means

Updated Category News Views 5

SOC as a Service: More Than Just Jargon The term 'SOC as a Service' (SOCaaS) might sound like some alphabet soup, but it’s a serious contender in today’s digital security world. With projected growth from $9.04 billion in 2026 to a whopping $16.68 billion by 2031, the SOCaaS market isn’t just having a moment, it’s setting up a stage for the long haul. It’s like...

Continue Reading
Baidu Faces Securities Fraud Lawsuit: Key Investor Alert

Updated Category News Views 3

Stormy Weather for Baidu Investors Digging through the latest on Baidu's (NASDAQ:BIDU) unsettling journey feels like watching a rerun of a soap opera you wish would just end. The company has been slapped with a class action lawsuit by The Law Offices of Frank R. Cruz, accusing them of pulling the wool over investors' eyes from November 18, 2025, to August 17, 2026....

Continue Reading
Cracking Down on Insider Trading: Legal vs Illegal

Updated Category News Views 9

Why the Insider Trading Line Isn't Always Clear-Cut Insider trading is one of those buzzwords that conjures up images of Wall Street shenanigans and pricey legal battles. But believe it or not, trading on insider info isn’t always a one-way ticket to a federal prison. What determines its legality often hinges on how the information was obtained and used. It's a...

Continue Reading
WOLFX Super App Surges with 300% Growth Post-Launch

Updated Category News Views 4

A Fast-Paced Entry into the College Scene College life isn’t getting any easier, but the WOLFX app is blazing a trail through U.S. campuses, promising to mend some of the chaos students deal with daily. It's barely taken a breath since launching just a month ago, already knitting itself into the routine of students from 104 universities in 130 cities across America -...

Continue Reading
OwnATC Empowers Trainers to Expand Access to Care

Updated Category News Views 2

The Untapped Potential of Athletic Trainers In a hustle to get people's bodies moving and grooving right, we often overlook a crucial player: the Certified Athletic Trainer (CAT). These folks have been shelved in schools or sports arenas for far too long, especially when their expertise could be lighting up communities across the map. Enter OwnATC, shaking things up. A...

Continue Reading
Wuhan Colposcopy Course Advances Non-Invasive Treatments

Updated Category News Views 1

Wuhan's Leap in Colposcopy Training Innovation Talk about shaking things up in the medical world—this 2026 CSCCP-ASCCP Colposcopy Training Course in Wuhan isn't just another run-of-the-mill gathering. It's a heavyweight clash of brainpower between the Chinese and American medical pros in the relentless battle against cervical lesions. But here's where it gets spicy: for...

Continue Reading
Warhound's $200M Bet on Genetic Superdogs

Updated Category News Views 7

Pioneering the Canine Frontier with Genetic Superdogs Well, they'd gone and done it. Launched from the shadows with a fat $200 million seed fund, Warhound's venturing where few have before: crafting America’s homegrown powerhouse of genetically enhanced military dogs. Picture your future Fido with a cyber boost and a genetic upgrade. This is Warhound’s battlefield,...

Continue Reading
Volvo Faces Rough Q3, Plans Strategic Responses

Updated Category News Views 5

Volvo's Bumpy Ride Through Q3 2026 Volvo Cars isn't painting a pretty picture for the third quarter of 2026. Posting an operating income of SEK -3.7 billion and a negative EBIT margin sitting at -5.6%, they're definitely feeling the heat. Market shifts in China and the U.S. are squeezing them, and it shows. Crunching the Numbers Let's break this down. Revenue nose-dived...

Continue Reading
Hexagon Composites to Release Q3 2026 Results Soon

Updated Category News Views 2

Anticipating Hexagon's Third Quarter 2026 Results Hexagon Composites ASA, based out of Oslo, Norway, is setting the stage to release its third quarter 2026 financial results. Mark your calendars for November 6, 2026, at the early bird hour of 07:00 am CET. For those of us keen on dissecting the numbers, that's when the real action begins. Executive Insights Await A...

Continue Reading
dMY IV Settlement: Investor Rights and Key Dates

Updated Category News Views 4

dMY IV Settlement: What You Need to Know Listen up, folks! If you've got a stake in dMY Technology Group, Inc. IV, there's big news brewing. We're talking class action, settlement talks, and a cool $11 million on the line. Let's crack open what this means for you as a holder of dMY IV Class A common stock during December 2021's whirlwind. Who Can Get a Piece of the...

Continue Reading

Top 5 Most Recently Viewed Articles

Metal Roofing Market Growth Expected to Reach $25.8 Billion

Updated Category News Views 56

The Rising Tide of the Metal Roofing Market The global metal roofing market is on track for significant growth, with projections indicating a compound annual growth rate (CAGR) of 5.3% through to 2031. Industry experts forecast that the total sales revenue for metal roofing solutions will reach a remarkable USD 25.8 billion by the end of this period. This remarkable...

Continue Reading
Piper Sandler Elevates Tesla Price Target Amid Growth Prospects

Updated Category News Views 52

Piper Sandler Raises Price Target for Tesla Piper Sandler has updated its price target for Tesla Inc (NASDAQ: TSLA), increasing it from $300 to $310. This change comes with an Overweight rating, signaling strong confidence in the company’s potential for growth. The adjustment is mainly due to improved expectations for vehicle deliveries in the upcoming financial period....

Continue Reading
Market Update: Mexico Stocks Fall Significantly at Close

Updated Category News Views 62

Market Insights: Mexico Stocks Decline The stock market in Mexico experienced a downturn recently, reflecting a challenging economic landscape. The S&P/BMV IPC index concluded the trading session with a notable decrease of 1.01%, highlighting a dip in various sectors and overall investor sentiment. Sector Performance: Key Drivers Behind the Decline Several sectors played...

Continue Reading
How a $100 Investment in Vertiv Holdings Co Could Grow Today

Updated Category News Views 116

The Growth Journey of Vertiv Holdings Co Investing in the stock market is often likened to planting a seed that grows given the right conditions. If you had invested $100 in Vertiv Holdings Co (NYSE: VRT) five years ago, your investment would have blossomed into a staggering $841.40 today. This impressive increase highlights the importance of not just investing, but...

Continue Reading
PACS Group Investors Urged to Act Amid Class Action Lawsuits

Updated Category News Views 143

Understanding PACS Group Class Action Lawsuits In recent developments, PACS Group, Inc. has encountered significant legal challenges as former Louisiana Attorney General Charles C. Foti, Jr., in association with Kahn Swick & Foti, LLC, has alerted investors regarding ongoing class action lawsuits. Investors who experienced losses exceeding $100,000 during the class period...

Continue Reading